Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Derwent London chair-designate Breuer buys shares

Thu, 11th Mar 2021 15:31

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:

----------

Derwent London PLC - property investment and development - Independent Non-Executive Director Mark Breuer buys 4,000 shares at GBP33.12, worth GBP132,468, on Thursday. Breuer, joined the board on February 1 and will replace John Burns as chair come Derwent's annual general meeting, tentatively scheduled for May 14.

----------

Abcam PLC - Cambridge, England-based supplier of life science research tools - Chief Executive Officer Alan Hirzel buys 2,500 shares at GBP14.86, worth GBP37,143, on Tuesday. Chief Financial Officer Michael Baldock buys 5,000 American Depositary Receipts at USD20.66, worth USD103,300, also on Tuesday.

----------

Sage Group PLC - Newcastle Upon Tyne-based accounting software - Chief Operating Officer Lee Perkins buys 15,000 shares at 588.76 pence, worth GBP88,314, on Thursday. Perkins now has 49,244 shares.

----------

Spirent Communications PLC - Crawley, England-based provider of testing, analytics and security for telecommunications networks - Elaine Sullivan, associate of Non-Executive Director Gary Bullard, buys 10,000 shares at GBP2.56, worth GBP25,592, on Thursday. Gary Bullard now is interested in 62,044 shares. Spirent on Thursday published its 2020 results, reporting pretax profit of USD95.8 million, up 6.9% from USD89.6 million in 2019.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Nov 2015 14:32

Abcam agrees AxioMx takeover

(ShareCast News) - Protein research tools producer Abcam has reached an agreement to acquire monoclonal antibodies producer AxioMx in a deal worth up to $45m (£29.7m). The London-listed company said it will pay $20m upfront for AxioMx, with a further $25m due based on the US-based company achieve ce

Read more
11 Nov 2015 08:56

Abcam Strikes Deal To Buy US-Based AxioMx For Up To USD45 Million

Read more
5 Nov 2015 16:31

Dividends Calendar - Week Ahead

Read more
5 Nov 2015 09:00

Abcam On Course To Meet Financial 2016 Expectations, Plans Investments

Read more
29 Oct 2015 16:13

AGM, EGM Calendar - Week Ahead

Read more
24 Sep 2015 16:20

DIRECTOR DEALINGS: ABCAM Company Secretary Smith Buys Shares

Read more
14 Sep 2015 07:21

LONDON BRIEFING: Chinese Industrial Production Disappoints

Read more
14 Sep 2015 06:37

ABCAM CFO To Step Down As It Says New Year Has Started Well

Read more
9 Sep 2015 06:54

Horizon Discovery Enters Licence, Supply Agreement With Abcam

Read more
8 Sep 2015 05:12

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Sep 2015 15:04

Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Jul 2015 13:41

Abcam "back on track" with strong full-year revenues

(ShareCast News) - Antibodies and protein research products producer Abcam said it has been attracting and retaining consumers to its business and delivering market revenue growth. The group added the year ended 30 June 2015, was a successful one driven by its strategy, with revenues expected to ris

Read more
23 Jul 2015 09:29

WINNERS AND LOSERS SUMMARY: Unilever, Kingfisher Up As Aberdeen, SSE Drop

Read more
23 Jul 2015 07:09

Abcam Expects To Post 12% Revenue Growth For Full Year

Read more
2 Jul 2015 08:44

BROKER RATINGS SUMMARY: Berenberg Raises AstraZeneca To Buy from Hold

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.